Observations placeholder
Ventavis
Identifier
020358
Type of Spiritual Experience
Background
A description of the experience
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. This damages the tissues and causes high blood pressure Iloprost works by opening (dilating) the blood vessels to allow the blood to flow through again.
Contraindications:
- unstable angina; within 6 months of myocardial infarction; decompensated cardiac failure (unless under close medical supervision); severe arrhythmias; congenital or acquired heart-valve defects; within 3 months of cerebrovascular events; pulmonary veno-occlusive disease; conditions which increase risk of bleeding.
Common side effects:
- In clinical studies, common adverse reactions due to inhaled iloprost included: vasodilation (flushing, 27%), cough (39%), headache (30%), flu syndrome (14%), nausea (13%), neck spasms (12%), hypotension (11%), insomnia (8%), and fainting (syncope) (8%); other serious adverse events reported with the use of Ventavis included congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, swelling of the limbs (especially around the ankles and feet), and kidney failure.
Serious adverse events reported with the use of inhaled iloprost include congestive heart failure, chest pain, supraventricular tachycardia, shortness of breath, peripheral edema, and kidney failure.
On Jan, 13, 2017 8,314 people reported to have side effects when taking Ventavis.
Among them, 10 people (0.12%) have Hallucination
Time on Ventavis when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 66.67% | 33.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Ventavis :
Female | Male | |
Hallucination | 77.78% | 22.22% |
On Feb, 18, 2016: 3,429 people reported to have side effects when taking Ventavis. Among them, 738 people (21.52%) have Death.
Time on Ventavis when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 17.90% | 24.07% | 17.90% | 18.52% | 19.14% | 2.47% | 0.00% |
Gender of people who have Death when taking Ventavis :
Female | Male | |
Death | 69.12% | 30.88% |
Age of people who have Death when taking Ventavis :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 2.30% | 0.57% | 1.15% | 2.30% | 5.17% | 12.64% | 10.92% | 64.94% |
Top conditions involved for these people :
- Pulmonary arterial hypertension (579 people, 78.46%)